Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
eli lilly
life sciences
national blog main
new york blog main
new york top stories
san francisco blog main
san francisco top stories
6
×
biotech
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
national top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer immunotherapy
clinical trials
deals
merck
startups
abbvie
alzheimer's disease
boehringer ingelheim
celgene
fda
johnson & johnson
What
bio
6
×
companies
6
×
roundup
drug
latest
life
nash
new
news
pharmaceutical
price
science
week
alzheimer’s
approval
approved
arena’s
bets
biogen’s
biopharmaceutical
black
bounty
cancer
cig
comeback
comes
continue
convo
corner
cut
date
deal
deals
debut
delivered
diamond
diamond’s
different
digital
disease
Language
unset
Current search:
bio
×
companies
×
" san francisco top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines